Recent Investment to Enhance Growth at EUDA Health
EUDA Health Holdings Limited (NASDAQ: EUDA), a prominent non-invasive healthcare provider based in Singapore, has announced a significant step forward in its growth strategy. The company has entered into a securities purchase agreement designed to bolster its capital resources. This announcement follows a deal with Streeterville Capital, LLC, where EUDA will sell a convertible warrant for a total amount of $100,000.
Details of the Securities Purchase Agreement
Under the terms of this agreement, the warrant enables Streeterville Capital to acquire up to 2,000,000 newly issued ordinary shares of EUDA at an exercise price of $6.00 each. This arrangement is part of EUDA's effort to leverage its effective shelf registration statement, which facilitates this financing approach.
Investment Partnership with Streeterville Capital
Streeterville Capital is an investment firm, known for its strategic investments in various companies across the United States. Their involvement with EUDA Health emphasizes their confidence in the company's growth trajectory and market potential.
Investment Terms and Potential Impact
The warrant's exercise period is set for ninety days post-issuance, allowing Streeterville Capital the option to purchase shares in cash during this timeframe. Moreover, if specific trading conditions are met, EUDA has the right to compel Streeterville to convert part of the warrant into equity, ensuring the company can manage its capital effectively.
CEO's Insights on the Agreement
Mr. Alfred Lim, CEO of EUDA, expressed optimism about the deal, highlighting how it enhances the company's financial foundation. He articulated that this investment will allow EUDA to pursue high-return initiatives, including new healthcare centers and technology advancements. This strategic funding will help them seize growth opportunities across Asia's burgeoning non-invasive healthcare sector.
About EUDA Health Holdings Limited
As a leader in the healthcare services sector, EUDA Health is on a mission to transform the way healthcare is delivered. The company is keenly focused on preventive care, particularly in the longevity sector, aiming to address the diverse healthcare needs of over 1.8 billion people in Asia. With the demographic landscape shifting, EUDA strives to offer innovative and scientifically-backed health solutions that will lead to a proactive approach in managing health.
Addressing Regional Healthcare Needs
EUDA aims to revolutionize regional healthcare by shifting from reactive medical responses to a more proactive, longevity-centered care model. Their initiatives not only serve to enhance patient welfare but also drive long-term value within the community and for stakeholders involved.
Contact Information
If you have inquiries regarding this release or about EUDA Health Holdings, you may reach out to:
Christensen Advisory
Linda Bergkamp
Phone: +1-480-614-3004
Email: linda.bergkamp@christensencomms.com
Frequently Asked Questions
What is the purpose of the securities purchase agreement?
The agreement aims to enhance EUDA Health's capital position and support growth initiatives, including the expansion of healthcare services.
Who is Streeterville Capital?
Streeterville Capital is an investment firm known for its strategic investments in various companies and supporting their growth plans.
How many shares can Streeterville Capital acquire?
Streeterville Capital has the option to acquire up to 2,000,000 new ordinary shares of EUDA Health.
What does the exercise price of $6.00 mean?
The exercise price refers to the amount Streeterville must pay per share to convert their warrant into equity in EUDA Health.
What is EUDA's mission?
EUDA's mission is to address the evolving healthcare needs across Asia by providing innovative non-invasive and preventive healthcare solutions.
